Observational studyInternational journal of cancer2025

Ramucirumab-containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum-based chemotherapy: A multicenter observational retrospective study (WJOG13420G).

Yuki Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.